Floatz logo

Shr-9839

Advanced Solid Tumors

Shandong Suncadia Medicine Co., Ltd.Phase 2Active
CCC
54/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
51/ 100
Competitive Position
59/ 100

Competitive context

435 Active assets in the Advanced Solid Tumors cohort.

Asset / SponsorPhaseRating
Eloxatin
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 4BB
FLUOROURACILUM
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
Irinotecan
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB
CIS-DIAMMINEDICHLOROPLATINUM II
InSilico Medicine Hong Kong Limited
Phase 4BB
Calcium folinate pentahydrate
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 3BB

View all 50 →

Same molecule, other indications

Shr-9839 is also rated in:

cancerDormant
BB
Indicative ·
65 / 100
View asset →
Advanced KRAS G12D Mutant Solid TumorsDormant
CC
Indicative ·
47 / 100
View asset →
non-small cell lung carcinomaDormant
CC
Indicative ·
43 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →